Braun J, Baraliakos X, Deodhar A. et al. Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology (Oxford) 2018; DOI: 10.1093/rheumatology/key375.
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.